The Results Are In:
The FIRST EVER Clinical Study of VigRX Plus™ With Real Men Is Now Complete.
. And The Results Are Outstanding!
In just 84 days, guys saw:
62.82% INCREASE in ability to maintain erection
58.97% INCREASE in ability to penetrate partner
22.49% INCREASE in frequency & quality of orgasms
71.43% INCREASE in sexual & intercourse satisfaction
47.00% INCREASE in sex drive and desire
61.00% INCREASE in overall sexual satisfaction
*Results shown were from a triple-blind placebo controlled, randomized Clinical Study by Vedic Lifesciences Pvt. LTD. Individual results may vary.
For the last ten years, we’ve been getting feedback directly from our customers about VigRX Plus™.
So we already knew that it was extremely potent.
But we have to admit, even we were a touch surprised when we received the results of our two-year clinical study, completed by Vedic Lifesciences Pvt. Ltd.
We knew it was good.
But we didn’t know it was THAT good!
If you like, you’re welcome to read the 56-page clinical study report that we received directly from Vedic Lifesciences.
However, we know you’re busy, so we’ve summarized a few of the most notable results below for your convenience:
An Explanation Of How The Study Was Conducted And Who Was Involved:
The clinical study was performed by Vedic Lifesciences Pvt. Ltd.
It was a triple-blind study, which means nobody involved in evaluating the results (doctors, researchers, etc.) knew whether participants were taking VigRX Plus™ or the placebo.
The trial ran for 84 days, with assessment visits taking place on Day 28, Day 56, and Day 84.
The results were assessed using the IIEF – the International Index of Erectile Function. This system of assessment is well respected throughout the international community and has demonstrated consistent treatment responsiveness in studies in the US, Europe, and Asia. It measures:
- Erection Frequency
- Erection Firmness
- Frequency of Partner Penetration
- Frequency of Maintaining An Erection After Penetration
- Ability To Maintain An Erection To Completion Of Intercourse
- Confidence In Achieving And Maintaining An Erection
Patient and partner satisfaction was measured using the internationally recognized EDITS questionnaire. And prior to the start of the study, the protocols and amendments were submitted to and formally approved by the Independent Institutional Ethics Commit (IEC).
Profile Of The Men Who Participated:
The 75 men who participated in the study were between the ages of 25 and 50, in monogamous, heterosexual relationships.
They agreed to take the recommended dose of VigRX Plus™ – 2 capsules, twice per day with meals for 12 weeks.
Out of 108 applicants screened, 78 were recruited for participation in the trial – and 75 completed the trial.
No participants had major psychiatric disorders, a history of heart conditions, diabetes, spinal cord injuries, deformities of the penis, HIV/Aids, or sexually transmitted diseases. None were alcoholics, used medications known to causes sexual dysfunction, had liver or renal dysfunction, erection issues caused by low testosterone, or had female partners who were pregnant.